NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 43 filers reported holding NEOS THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $2,612,000 | -35.3% | 446,443 | -27.3% | 0.00% | -100.0% |
Q3 2016 | $4,038,000 | -23.1% | 613,698 | +8.4% | 0.00% | 0.0% |
Q2 2016 | $5,254,000 | +36.4% | 566,112 | +58.5% | 0.00% | 0.0% |
Q1 2016 | $3,853,000 | -20.0% | 357,058 | +6.2% | 0.00% | 0.0% |
Q4 2015 | $4,815,000 | +58.4% | 336,227 | +132.3% | 0.00% | 0.0% |
Q3 2015 | $3,040,000 | – | 144,714 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DSC Advisors, L.P. | 1,043,770 | $7,620,000 | 2.51% |
Stonepine Capital Management, LLC | 565,100 | $4,125,000 | 2.23% |
DAFNA Capital Management LLC | 209,873 | $1,532,000 | 1.09% |
Ghost Tree Capital, LLC | 500,000 | $3,650,000 | 0.76% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,459,195 | $10,652,000 | 0.57% |
PURA VIDA INVESTMENTS, LLC | 150,000 | $1,095,000 | 0.44% |
J. Goldman & Co LP | 845,000 | $6,169,000 | 0.33% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 191,729 | $1,400,000 | 0.20% |
Opaleye Management Inc. | 50,000 | $365,000 | 0.15% |
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC | 50,000 | $365,000 | 0.15% |